Pacer Advisors’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-11,863
| Closed | -$277K | – | 3704 |
|
2024
Q3 | $277K | Buy |
11,863
+9,946
| +519% | +$233K | ﹤0.01% | 1762 |
|
2024
Q2 | $34.1K | Sell |
1,917
-625
| -25% | -$11.1K | ﹤0.01% | 3291 |
|
2024
Q1 | $38.7K | Buy |
+2,542
| New | +$38.7K | ﹤0.01% | 3272 |
|
2021
Q2 | – | Sell |
-1,562
| Closed | -$75K | – | 1554 |
|
2021
Q1 | $75K | Sell |
1,562
-1,568
| -50% | -$75.3K | ﹤0.01% | 1346 |
|
2020
Q4 | $163K | Sell |
3,130
-2,988
| -49% | -$156K | ﹤0.01% | 1268 |
|
2020
Q3 | $164K | Buy |
+6,118
| New | +$164K | ﹤0.01% | 1206 |
|
2018
Q4 | – | Sell |
-10,626
| Closed | -$60K | – | 994 |
|
2018
Q3 | $60K | Buy |
+10,626
| New | +$60K | ﹤0.01% | 1133 |
|
2018
Q1 | – | Sell |
-3,425
| Closed | -$28K | – | 1127 |
|
2017
Q4 | $28K | Buy |
+3,425
| New | +$28K | ﹤0.01% | 1075 |
|